We are live on ! Find out more
PAIA

Park Avenue Institutional Advisers Portfolio holdings

AUM $199M
1-Year Est. Return 36.92%
This Fund
S&P 500
This Quarter Est. Return
+0.18%
1 Year Est. Return
+36.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$199M
AUM Growth
-$514K
Cap. Flow
-$882K
Cap. Flow %
-0.44%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed
3

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$497K
2
BRZE icon
Braze
BRZE
+$210K
3
TTAN
ServiceTitan Inc
TTAN
+$175K

Sector Composition

Rank Sector Weight
1 Healthcare 0%
2 Technology 0%

No holdings matched the selected filter criteria.

Similar funds

Park Avenue Institutional Advisers's Q2 2026 Portfolio in Review

As of Q2 2026, Park Avenue Institutional Advisers held 5 positions worth $199M, down 0.26% from $199M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Park Avenue Institutional Advisers's Q2 2026 filing shows 3 closed positions. The largest sale was Revolution Medicines, an estimated $497K.

By sector, the portfolio is most concentrated in Healthcare at 0% of assets, down from 0.25% a quarter earlier, followed by Technology.

  • Park Avenue Institutional Advisers fully exited Revolution Medicines in Q2 2026, selling an estimated $497K.
  • Park Avenue Institutional Advisers's ten largest holdings make up 100% of its $199M portfolio in Q2 2026.
  • Park Avenue Institutional Advisers opened 0 new positions and closed 3 in Q2 2026.
  • Park Avenue Institutional Advisers's portfolio value fell 0.26% quarter-over-quarter to $199M.

Based on Park Avenue Institutional Advisers's 13F filing for Q2 2026, filed 4 Aug 2026.